Evidence map›Paper›PMID 26338321›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Soluble Tumor Necrosis Factor Alpha Promotes Retinal Ganglion Cell Death in Glaucoma via Calcium-Permeable AMPA Receptor Activation.

Jorge L Cueva Vargas, Ingrid K Osswald, Nicolas Unsain, Mark R Aurousseau, Philip A Barker, Derek Bowie, Adriana Di Polo

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 127 citations in OpenAlex.

  1. Neuroinflammation in glaucoma: a myriad of cellular pathways and players.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. L- and T-type CaNeural regeneration research · 2023
    Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jorge L Cueva VargasDepartment of Neuroscience and University of Montreal Hospital Research Center (CRCHUM), University of Montreal, Montreal, Quebec H2X 0A9, Canada.
Ingrid K OsswaldDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Quebec H3G 1Y6, Canada, and.
Nicolas UnsainCentre for Neuronal Survival, Montreal Neurological Institute, Montreal, Quebec H3A 2B4, Canada.
Mark R AurousseauDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Quebec H3G 1Y6, Canada, and.
Philip A BarkerCentre for Neuronal Survival, Montreal Neurological Institute, Montreal, Quebec H3A 2B4, Canada.ORCID http://orcid.org/0000-0002-3444-7551
Derek BowieDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Quebec H3G 1Y6, Canada, and.ORCID http://orcid.org/0000-0001-9491-8768
Adriana Di PoloDepartment of Neuroscience and University of Montreal Hospital Research Center (CRCHUM), University of Montreal, Montreal, Quebec H2X 0A9, Canada, adriana.di.polo@umontreal.ca.
McGill University · CAMontreal Neurological Institute and Hospital · CAUniversité de Montréal · CA

Funding

Canadian Institutes of Health Research CIHR-VIH-105439
6 · The paper itself

Abstract

Loss of vision in glaucoma results from the selective death of retinal ganglion cells (RGCs). Tumor necrosis factor α (TNFα) signaling has been linked to RGC damage, however, the mechanism by which TNFα promotes neuronal death remains poorly defined. Using an in vivo rat glaucoma model, we show that TNFα is upregulated by Müller cells and microglia/macrophages soon after induction of ocular hypertension. Administration of XPro1595, a selective inhibitor of soluble TNFα, effectively protects RGC soma and axons. Using cobalt permeability assays, we further demonstrate that endogenous soluble TNFα triggers the upregulation of Ca(2+)-permeable AMPA receptor (CP-AMPAR) expression in RGCs of glaucomatous eyes. CP-AMPAR activation is not caused by defects in GluA2 subunit mRNA editing, but rather reflects selective downregulation of GluA2 in neurons exposed to elevated eye pressure. Intraocular administration of selective CP-AMPAR blockers promotes robust RGC survival supporting a critical role for non-NMDA glutamate receptors in neuronal death. Our study identifies glia-derived soluble TNFα as a major inducer of RGC death through activation of CP-AMPARs, thereby establishing a novel link between neuroinflammation and cell loss in glaucoma. SIGNIFICANCE STATEMENT: Tumor necrosis factor α (TNFα) has been implicated in retinal ganglion cell (RGC) death, but how TNFα exerts this effect is poorly understood. We report that ocular hypertension, a major risk factor in glaucoma, upregulates TNFα production by Müller cells and microglia. Inhibition of soluble TNFα using a dominant-negative strategy effectively promotes RGC survival. We find that TNFα stimulates the expression of calcium-permeable AMPA receptors (CP-AMPAR) in RGCs, a response that does not depend on abnormal GluA2 mRNA editing but on selective downregulation of the GluA2 subunit by these neurons. Consistent with this, CP-AMPAR blockers promote robust RGC survival supporting a critical role for non-NMDA glutamate receptors in glaucomatous damage. This study identifies a novel mechanism by which glia-derived soluble TNFα modulates neuronal death in glaucoma.

Indexed as

AnimalsCalciumCarrier ProteinsCell DeathCholine O-AcetyltransferaseCobaltDisease Models, AnimalEpendymoglial CellsGlaucomaMaleMicrogliaRatsReceptors, AMPAReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IIRetinal Ganglion CellsCalciumCarrier ProteinsCholine O-AcetyltransferaseCobaltglutamate receptor ionotropic, AMPA 2Receptors, AMPAReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IISaline Solution, HypertonicTnfrsf1a protein, ratTumor Necrosis Factor-alphaXENP 1595AMPA receptorcalciumglaucomaneuroinflammationretinal ganglion celltumor necrosis factor

Identifiers

PMID26338321
PMCPMC6605307
OpenAlexW1843574900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.